Dosentrx is defining the category of Therapy Performance Management. The ReX® Therapy Intelligence Platform enables drug performance to be continuously optimized beyond the point of dispensing.
Healthcare operates on assumptions once therapy begins. Billions are spent, yet there is almost no visibility into whether therapy actually performs. The cause is the Therapy Blind Spot.
The Therapy Blind Spot hides the behaviors, patient experiences, risk signals and intervention opportunities that determine drug performance. Now, therapy performance is manageable and provable through the Therapy Performance Pathway.
The visibility gap between prescription and outcome. Once therapy begins, performance is assumed.
Confirmed dosing behavior plus patient-reported context (ePRO), captured in the moment.
Behavior and ePRO thresholds become actionable intervention opportunities.
Targeted pharmacist and care-team action, with full visibility and documentation.
Measurable improvement across the metrics that matter.
The data asset that connects behavior, intervention, and outcomes.
The ReX® Therapy Intelligence Platform is the system powering Therapy Performance Management. It produces a new class of real-world data, anchored to the dosing event and connected to the outcome.
Without visibility to patient context care is reactive. With Therapy Performance Management, intervention happens earlier and with precision.
The Therapy Performance Pathway applies across the healthcare ecosystem and brings specific benefits to each stakeholder.
See where visibility is lost, where intervention fails, and where performance can improve.